The 2026 Morgan Stanley Global Healthcare Conference highlighted how biopharma and healthcare executives are balancing patent cliffs, strategic acquisitions and rapid AI integration to sustain long term growth.
Morgan Stanley's 24th Annual Global Healthcare Conference ran in New York from Monday 14 to roughly Wednesday 16 September 2026, drawing around 3,000 investors and executives across biopharma, biotech, medtech and health services. Company sessions were the usual fireside-chat format with live webcasts: Merck's CEO Robert Davis and R&D head Dean Li spoke on the Monday, and Tuesday featured Amgen (Jay Bradner and CFO Thomas Dittrich), AbbVie, STERIS, Sight Sciences and others,
Nelson Advisors
Sep 19
Add a title here. Make it bold and impactful. Click to edit.
Nelson Advisors specialise in Mergers and Acquisitions for European HealthTech, MedTech, Digital Health, Healthcare IT, Healthcare AI companies in the Lower to Mid Market ranging from $25M to $250M EV.
